tiprankstipranks
RepliCel Life Sciences Inc (TSE:RP)
:RP
Canadian Market
Holding TSE:RP?
Track your performance easily

RepliCel Life Sciences (RP) Financial Statements

4 Followers

RepliCel Life Sciences Financial Overview

RepliCel Life Sciences's market cap is currently ―. The company's EPS TTM is C$0.022; its P/E ratio is ―; RepliCel Life Sciences is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 88.43K$ 88.43K$ 88.43K$ 88.43K$ 88.43K
Gross Profit$ 88.43K$ 88.43K$ 88.43K$ 88.43K$ 88.43K
EBIT$ -216.22K$ -187.94K$ -127.53K$ 2.22M$ -385.78K
EBITDA$ -189.29K$ -169.98K$ -118.55K$ 2.26M$ -385.88K
Net Income Common Stockholders$ -216.22K$ -187.94K$ -251.83K$ 2.03M$ -818.60K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.46K$ 148.95K$ 16.64K$ 76.41K$ 32.48K
Total Assets$ 150.97K$ 302.57K$ 202.53K$ 287.79K$ 331.46K
Total Debt$ 467.54K$ 423.16K$ ―$ ―$ ―
Net Debt$ 457.07K$ 274.21K$ ―$ ―$ ―
Total Liabilities$ 5.34M$ 5.15M$ 4.99M$ 4.82M$ 6.97M
Stockholders Equity$ -5.19M$ -4.98M$ -4.78M$ -4.53M$ -6.64M
Cash Flow-
Free Cash Flow$ -425.71K$ -284.16K$ -160.13K$ 337.49K$ -200.29K
Operating Cash Flow$ -425.71K$ -284.16K$ -160.13K$ 337.49K$ -200.29K
Investing Cash Flow$ 17.25K$ 17.25K$ 17.25K--
Financing Cash Flow$ 359.76K$ 315.13K$ 100.36K$ 1.06M$ -2.00
Currency in USD

RepliCel Life Sciences Earnings and Revenue History

RepliCel Life Sciences Debt to Assets

RepliCel Life Sciences Cash Flow

RepliCel Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis